The European market for clot management devices consists of a combination of rapidly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatment of AV access thrombosis, PADVTECAD, and AIS. Device adoption throughout these market segments hinges largely on reimbursement, which depends on positive clinical and economic evidence.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for clot management devices in Europe across a 10-year period.


Expansion of endovascular clot management procedure volumes hinges on obtaining conclusive evidence demonstrating the comparative efficacy of these procedures over the current standard of care. 

What factors will limit immediate growth, and are these limiters region-specific?

Which segments will benefit the most from emerging clinical evidence and to what extent?

How will the expanding use of novel oral anticoagulants affect clot management procedures?

Some large clinical trials have failed to show a benefit for endovascular clot management.

How will negative results of the ATTRACT trial impact clot management procedures in the VTE indication?

How will the results of the TOTAL trial impact clot management procedures in the coronary indication?

Will the data from the TOTAL and ATTRACT trials have an impact on the overall clot management device market?

Price consciousness and inadequate reimbursement represent major limiters for the uptake of premium-priced technologies in the European clot management device market.

What effect will varying reimbursement across the countries covered have on their respective markets?

How will cost consciousness in Europe affect device ASPs in different product segments?

What strategies can competitors use to compete effectively in economically constrained regions?

How are purchasing dynamics shifting in different European markets?

A recent influx of clinical data supporting the effectiveness of neurovascular thrombectomy procedures for the treatment of ischemic stroke will fuel this market segment.

What factors limit growth of this rapidly expanding market?

How will new entrants change the competitive landscape?

How long will robust growth in this market be sustained?

Table of contents

  • Europe
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Key Report Updates
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Version History
    • Clot Management Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Clot Management Procedures
        • Clot Management Device Market
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Pricing Strategies and Purchasing Options
        • Mergers, Acquisitions, and Partnerships
        • Product Portfolio Management
        • Clinical Data
        • Product Improvements and Innovations
        • Reimbursement
        • Physician Training and Marketing
        • Local Marketing Strategies
      • Market Developments
    • Percutaneous Thrombectomy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Manual Aspiration Thrombectomy Devices
        • Mechanical Thrombectomy Devices
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Pricing Strategies and Purchasing Options
        • Product Portfolio Management
        • Clinical Data
        • Product Improvements and Innovations
    • Embolectomy Balloon Catheter Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Catheter-Directed Thrombolysis Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Inferior Vena Cava Filter Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
    • Neurovascular Thrombectomy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Product Portfolio Management
        • Product Improvements and Innovations
        • Physician Training and Marketing
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Yang Yun Li, PhD

Yang Yun Li is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in clot management device markets. Yang holds a in Pharmaceutical Sciences from the University of Toronto.


Related Reports

Clot Management Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European market for clot management devices is characterized by a combination of rapidly expanding and relatively mature market segments, where device adoption hinges largely on positive cli...

View Details

Clot Management Devices | Medtech 360 | Market Insights | Japan

The Japanese market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatme...

View Details

Clot Management Devices | Medtech 360 | Market Insights | United States

The US market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatmen...

View Details

Clot Management Devices | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

The Asia Pacific market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the tre...

View Details